NCT06879938View on ClinicalTrials.gov

Concomitant Treatment with Topical Hyaluronic Acid and High Concentration Oxygen Therapy (Vaginal Natural Oxygenation Device - VNOD) in the Improvement of Symptoms Related to Genitourinary Syndrome of Menopause in Women with Natural and Oncological Postmenopause: Open-Label, Single-Center, Randomize

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

October 16, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Genitourinary Syndrome of Menopause
Interventions
DEVICE

High-concentration vaginal oxygen therapy (Caress Flow) with topical hyaluronic acid

five treatment sessions of high-concentration vaginal oxygen therapy (Caress Flow) with topical hyaluronic acid 2 weeks apart with a duration of approximately 15 minutes

DEVICE

hyaluronic acid-based gel (Hydeal-D®)

hyaluronic acid-based gel (Hydeal-D®) applied once every three days for 12 weeks

Trial Locations (1)

27100

RECRUITING

Fondazione IRCCS Policlinico San Matteo, SSD Ostetricia e Ginecologia 2 - Riproduzione e Procreazione Medicalmente Assistita, Pavia

All Listed Sponsors
lead

Fondazione IRCCS Policlinico San Matteo di Pavia

OTHER